Aperam (APEMY)
(Delayed Data from OTC)
$25.34 USD
0.00 (0.00%)
Updated Sep 9, 2024 12:16 PM ET
3-Hold of 5 3
A Value B Growth A Momentum A VGM
Price, Consensus and EPS Surprise
APEMY 25.34 0.00(0.00%)
Will APEMY be a Portfolio Killer in September?
Zacks Investment Research is releasing its prediction for APEMY based on the 1-3 month trading system that more than doubles the S&P 500.
About Price, Consensus and EPS Surprise
The Price, Consensus and EPS Surprise chart displays the company's stock price along with the consensus estimate and the EPS surprise. Zacks tracks individual sell-side analyst estimates and creates a consensus EPS estimates. The consensus estimate is the average of all the current estimates made available by brokerage analysts. Consensus estimates are more advantageous because they reduce the risk of any single analyst making an incorrect forecast. ZACKS CONSENSUS ESTIMATE = THE AVERAGE OF ALL CURRENT EPS ESTIMATES. EPS Surprise is the difference (expressed as a percentage) between the actual reported quarterly earnings per share (EPS) vs the estimated quarterly EPS. A company that reports $1.10 in actual quarterly EPS vs. $1.00 in estimated quarterly EPS would show a 10% positive EPS surprise. ((Actual EPS - Estimated EPS) / absolute Estimated EPS) *100 = EPS Surprise %.
Zacks News for APEMY
Is Aperam (APEMY) Stock Undervalued Right Now?
All You Need to Know About Aperam (APEMY) Rating Upgrade to Strong Buy
APEMY: What are Zacks experts saying now?
Zacks Private Portfolio Services
Should Value Investors Buy Aperam (APEMY) Stock?
Aperam (APEMY) Flat As Market Sinks: What You Should Know
Are Basic Materials Stocks Lagging Aperam (APEMY) This Year?
Other News for APEMY
Aperam S.A. goes ex dividend today
Aperam SA (APEMY) Q2 2024 Earnings Call Transcript Highlights: Revenue Growth Amidst Margin ...
Aperam price target raised by EUR 1.80 at JPMorgan
Barclays Reaffirms Their Sell Rating on Aperam S.A. (0OLF)
Aperam price target lowered by EUR 4.60 at JPMorgan